Why Is PRECIGEN INC (PGEN) Stock Up Today?

Why PGEN stock is up today

Precigen Inc stock rose 4.60% to $7.62 in early trading on August 26 driven by a strong earnings report and positive analyst coverage. The stock opened with a 1.8% gap up and reached an intraday high of $7.66 shortly after the market opened. The move followed the company’s Q2 earnings release which showed a $0.05 per share profit beating the estimated loss of $0.01 and revenue of $54.978 million surpassing the expected $27.833 million.

What Happened

Precigen’s Q2 results marked a commercial inflection with revenue increasing by 1875% year to date. The stock’s upward momentum was further supported by a recent analyst upgrade from HC Wainwright & Co which raised its price target to $18. The company’s stock has been volatile with a beta of 1.01 and a 52-week range of $2.99 to $7.55. The current price of $7.62 is just above the 52-week high. The stock opened at $7.41 and traded as low as $7.28 before closing the session at $7.62. Volume in the session was 1.2 million shares which is 0.2 times the 3-month average.

What The Data Shows

The 52-week tape showed 14 fresh 52-week highs and 2 fresh 52-week lows on August 26. Insider transactions in the last 90 days included 1 buy totaling $25000 and 13 sells totaling $6.6 million. Recent insider activity includes a purchase by Nancy H Agee a director and sales by Phil Tennant the Chief Commercial Officer and Rutul R Shah the COO. The stock remains unprofitable with an EPS of -0.98 over the trailing twelve months and a net margin of -184.0%.

What To Watch

Investors should monitor the company’s upcoming coverage breadth as well as any further analyst commentary. The stock’s performance may also be influenced by continued insider activity and broader market trends in the healthcare sector.